SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is seeing highly polarized community discussion following its recent earnings report, with bulls highlighting robust international growth, subscriber figures, and high short interest, while bears focus on slowing growth in certain segments and the lingering uncertainty from a lawsuit regarding GLP-1 offerings.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is experiencing significant buzz following a new strategic partnership with Astellas Pharma for its PSMA-targeting T-cell engager in prostate cancer, with the community highlighting substantial upfront payments and promising early-phase data, while some traders express skepticism about the rally's endurance.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix (NFLX) is at the center of an escalating bidding war for Warner Bros. Discovery (WBD), with Paramount Skydance (PSKY) reportedly submitting a superior offer, sparking intense community debate over whether Netflix will counter or choose to walk away and potentially benefit from a significant break-up fee amid regulatory uncertainties.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros Discovery (WBD) is trending as it reopens deal talks with Paramount Skydance (PSKY), which has sweetened its offer to acquire WBD by including Netflix's breakup fee. The community is debating whether this revised PSKY bid, or Netflix's existing board-recommended offer, provides the most compelling value and regulatory certainty for WBD shareholders in this intensifying media consolidation battle.

Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.

Protara Therapeutics Inc

Protara Therapeutics is trending due to recent interim Phase 2 data for its bladder cancer treatment, TARA-002, reporting a strong 6-month complete response rate, alongside a public stock offering. The community is largely perplexed by the subsequent significant price drop, with many seeing it as an undervaluation despite strong long-term pipeline potential.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to a sharp sell-off following Anthropic's announcement of AI tools for COBOL modernization, a core IBM business. Despite the market's overreaction, the community notes IBM's existing partnership with Anthropic and robust fundamentals in AI and quantum computing, leading many to see a significant buying opportunity amidst broader software sector concerns.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense & Security Solutions is trending after an earnings and revenue beat, bolstered by significant contract wins in its drone, hypersonics, and space sectors, including a near half-billion dollar program and its selection for the U.S. Department of War's Drone Dominance Program, sparking active community discussion on its valuation and growth within the defense sector.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending due to its enhanced bid for Warner Bros. Discovery, which addresses financial and regulatory concerns, intensifying the acquisition battle as Netflix faces mounting antitrust scrutiny and political challenges, shifting community focus to PSKY's potentially clearer path to the deal.

Super Group (SGHC) Ltd. is a global digital gaming company, which engages in the global online sports betting and gaming businesses, Betway, a premier online sports betting brand, and Spin, a multi-brand online casino offering. It operates through the following segments: Betway, Spin, and Other. The Betway segment focuses on the ingle brand online sportsbook and online casino focused business with a global footprint and strategic partnerships. The Spin segment relates to the multi-brand online casino focused business with established market leadership in high-growth markets. The company was founded in July 2020 and is headquartered in St. Peter Port, the United Kingdom.

Super Group (SGHC) Limited

Super Group (SGHC) is trending after exceeding Q2 earnings and revenue expectations, raising full-year guidance, and announcing a significant 25% increase to its quarterly dividend, while strategically exiting the US market to focus on its profitable international growth. The community is actively discussing these strong fundamentals, robust cash position, and a potential short squeeze, which positions SGHC favorably against US-centric peers navigating the evolving landscape of prediction markets.

20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in May 2000 and is headquartered in Gaithersburg, MD.

20/20 Biolabs Inc

AIDX is trending due to a steep post-IPO decline, with the community debating if it's a pump-and-dump as it seeks a bottom amidst sector-wide pressure in the liquid biopsy space. Many are expressing skepticism about its early cancer detection blood test business model, drawing comparisons to past controversial companies in the sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amarin (AMRN) to Release Quarterly Earnings on Wednesday

Amarin (NASDAQ:AMRN) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...

Amarin (NASDAQ:AMRN) Stock Rating Lowered by Zacks Research

Zacks Research downgraded shares of Amarin from a "hold" rating to a "strong sell" rating in a research note on Tuesday...

New Strong Sell Stocks for January 28th

AMRN, AMTB and AAWH have been added to the Zacks Rank #5 (Strong Sell) List on January 28th, 2026.

FY2025 EPS Estimates for Amarin Decreased by Zacks Research

Amarin Corporation PLC (NASDAQ:AMRN - Free Report) - Equities research analysts at Zacks Research cut their FY2025 earnings per share estimates for Amarin in a research note issued on Thursday...

BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock?

BioNTech (BNTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Do Options Traders Know Something About Amarin Stock We Don't?

Investors need to pay close attention to AMRN stock based on the movements in the options market lately. 

AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations

AMRN jumps 17% after Q4 and FY2025 preliminary sales beat expectations. The release also reflected positive Q4 cash flow and progress on cost cuts.

Zacks Research Analysts Lower Earnings Estimates for Amarin

Amarin Corporation PLC (NASDAQ:AMRN - Free Report) - Research analysts at Zacks Research reduced their FY2025 EPS estimates for shares of Amarin in a research note issued to investors on Monday...

Validea Kenneth Fisher Strategy Daily Upgrade Report - 12/9/2025

The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit...

Amarin Corporation PLC $AMRN Shares Sold by Steward Partners Investment Advisory LLC

Steward Partners Investment Advisory LLC reduced its holdings in shares of Amarin Corporation PLC (NASDAQ:AMRN - Free Report) by 92.9% during the 2nd quarter, according to its most recent 13F filing...

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

AMRN
Amarin Corp - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMRN News

AMRNAmarin Corp - ADR